Asian Dividend Stocks To Watch In April 2025
Name
Dividend Yield
Dividend Rating
Yangzijiang Shipbuilding (Holdings) (SGX:BS6)
6.21%
★★★★★★
CAC Holdings (TSE:4725)
5.44%
★★★★★★
Tsubakimoto Chain (TSE:6371)
5.06%
★★★★★★
Intelligent Wave (TSE:4847)
4.57%
★★★★★★
Nissan Chemical (TSE:4021)
4.21%
★★★★★★
ENEOS Holdings (TSE:5020)
4.24%
★★★★★★
HUAYU Automotive Systems (SHSE:600741)
4.48%
★★★★★★
Yamato Kogyo (TSE:5444)
4.35%
★★★★★★
E J Holdings (TSE:2153)
5.47%
★★★★★★
Torigoe (TSE:2009)
5.67%
★★★★★★
Click here to see the full list of 1310 stocks from our Top Asian Dividend Stocks screener.
Here's a peek at a few of the choices from the screener.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Dong-E-E-Jiao Ltd. engages in the research, development, production, and sale of Ejiao along with Chinese patent medicines and health foods, with a market cap of CN¥39.16 billion.
Operations: Dong-E-E-Jiao Ltd. generates revenue primarily from the operation of Ejiao and its related products, amounting to CN¥5.92 billion.
Dividend Yield: 4.2%
Dong-E-E-Jiao Ltd. has shown notable earnings growth, with net income rising to CNY 1.56 billion in 2024 from CNY 1.15 billion the previous year, but its dividend sustainability remains a concern due to a high payout ratio of nearly 100%. Despite being among the top dividend payers in China with a yield of 4.17%, the company's dividends have been volatile and not well covered by earnings or cash flows, impacting reliability for income-focused investors.
Dive into the specifics of Dong-E-E-JiaoLtd here with our thorough dividend report.
Our expertly prepared valuation report Dong-E-E-JiaoLtd implies its share price may be lower than expected.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of medical products, with a market cap of approximately CN¥55.12 billion.
Operations: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. generates revenue from its primary segments, with CN¥24.24 billion from Pharmaceuticals, CN¥0.88 billion from Printing and Packaging, and CN¥4.17 billion from the Medicines, Equipment Wholesale and Retail Industry Segment.
Dividend Yield: 3.1%
China Resources Sanjiu Medical & Pharmaceutical's dividend yield of 3.08% ranks it in the top 25% of Chinese dividend payers, supported by a cash payout ratio of 46.9%, indicating solid coverage by cash flows. However, its dividends have been volatile over the past decade, affecting reliability despite recent earnings growth to CNY 3.37 billion in 2024 from CNY 2.85 billion a year earlier and a reasonable earnings payout ratio of 50.2%.
Get an in-depth perspective on China Resources Sanjiu Medical & Pharmaceutical's performance by reading our dividend report here.
In light of our recent valuation report, it seems possible that China Resources Sanjiu Medical & Pharmaceutical is trading behind its estimated value.
Simply Wall St Dividend Rating: ★★★★★★
Overview: Ono Pharmaceutical Co., Ltd. and its subsidiaries engage in the production, purchase, and sale of pharmaceuticals and diagnostic reagents globally, with a market cap of ¥762.34 billion.
Operations: Ono Pharmaceutical Co., Ltd. generates revenue of ¥487.33 billion from its pharmaceutical business segment.
Dividend Yield: 4.9%
Ono Pharmaceutical offers a compelling dividend profile with a yield of 4.93%, placing it in the top quartile of Japanese dividend payers. Its dividends are well-supported by earnings and cash flows, with payout ratios of 50.8% and 49.6%, respectively, ensuring sustainability. Despite recent profit margin declines to 15.2% from last year's 25.6%, dividends have remained stable and reliable over the past decade, although earnings are projected to decrease by an average of 2.5% annually for the next three years.
Delve into the full analysis dividend report here for a deeper understanding of Ono Pharmaceutical.
Our valuation report unveils the possibility Ono Pharmaceutical's shares may be trading at a discount.
Access the full spectrum of 1310 Top Asian Dividend Stocks by clicking on this link.
Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SZSE:000423 SZSE:000999 and TSE:4528.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Exxon Mobil Second Quarter 2025 Earnings: Beats Expectations
Exxon Mobil (NYSE:XOM) Second Quarter 2025 Results Key Financial Results Revenue: US$80.0b (down 12% from 2Q 2024). Net income: US$7.08b (down 23% from 2Q 2024). Profit margin: 8.8% (down from 10% in 2Q 2024). The decrease in margin was driven by lower revenue. EPS: US$1.64 (down from US$2.14 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Exxon Mobil Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates by 4.5%. Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 3.7% growth forecast for the Oil and Gas industry in the US. Performance of the American Oil and Gas industry. The company's share price is broadly unchanged from a week ago. Balance Sheet Analysis Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Exxon Mobil's balance sheet. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
8 hours ago
- Yahoo
AKITA Drilling Second Quarter 2025 Earnings: EPS: CA$0.06 (vs CA$0.012 loss in 2Q 2024)
AKITA Drilling (TSE:AKT.A) Second Quarter 2025 Results Key Financial Results Revenue: CA$49.6m (up 29% from 2Q 2024). Net income: CA$2.30m (up from CA$478.0k loss in 2Q 2024). Profit margin: 4.6% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. EPS: CA$0.06 (up from CA$0.012 loss in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period AKITA Drilling Earnings Insights Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Energy Services industry in Canada. Performance of the Canadian Energy Services industry. The company's shares are up 5.2% from a week ago. Risk Analysis Before we wrap up, we've discovered 1 warning sign for AKITA Drilling that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
8 hours ago
- Yahoo
Estimating The Intrinsic Value Of Xcel Energy Inc. (NASDAQ:XEL)
Key Insights The projected fair value for Xcel Energy is US$72.16 based on Dividend Discount Model Current share price of US$73.47 suggests Xcel Energy is potentially trading close to its fair value Analyst price target for XEL is US$76.93, which is 6.6% above our fair value estimate How far off is Xcel Energy Inc. (NASDAQ:XEL) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Don't get put off by the jargon, the math behind it is actually quite straightforward. Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. The Method We have to calculate the value of Xcel Energy slightly differently to other stocks because it is a electric utilities company. Instead of using free cash flows, which are hard to estimate and often not reported by analysts in this industry, dividends per share (DPS) payments are used. This often underestimates the value of a stock, but it can still be good as a comparison to competitors. The 'Gordon Growth Model' is used, which simply assumes that dividend payments will continue to increase at a sustainable growth rate forever. The dividend is expected to grow at an annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.9%. We then discount this figure to today's value at a cost of equity of 6.4%. Relative to the current share price of US$73.5, the company appears around fair value at the time of writing. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate) = US$2.5 / (6.4% – 2.9%) = US$72.2 The Assumptions We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Xcel Energy as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.4%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for Xcel Energy SWOT Analysis for Xcel Energy Strength Earnings growth over the past year exceeded the industry. Weakness Interest payments on debt are not well covered. Dividend is low compared to the top 25% of dividend payers in the Electric Utilities market. Opportunity Annual earnings are forecast to grow for the next 3 years. Good value based on P/E ratio compared to estimated Fair P/E ratio. Threat Debt is not well covered by operating cash flow. Paying a dividend but company has no free cash flows. Annual earnings are forecast to grow slower than the American market. Moving On: Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. DCF models are not the be-all and end-all of investment valuation. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Xcel Energy, there are three additional factors you should look at: Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Xcel Energy (at least 1 which is a bit concerning) , and understanding these should be part of your investment process. Future Earnings: How does XEL's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NASDAQGS every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
